Cargando…
Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
Pancreatic cancer is one of the most aggressive and deadly malignancies. Despite better understanding of its biology and pathogenesis, contemporary treatment regimens are still insufficient. Along with the introduction of new treatment agents and combination therapy, the response rates are increasin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047971/ https://www.ncbi.nlm.nih.gov/pubmed/27713776 http://dx.doi.org/10.5114/pg.2016.61438 |